DoubleLine ETF Adviser’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Sell
6,079
-651
-10% -$223K 0.91% 35
2026
Q1
$2.37M Buy
+6,730
New +$2.4M 0.9% 30

Other funds holding AMGN

DoubleLine ETF Adviser's AMGN Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Amgen (AMGN) stake by 9.7% in Q2 2026, selling an estimated $223K and leaving 6,079 shares worth $2.2M. The position accounts for 0.91% of the portfolio, ranked #35.

DoubleLine ETF Adviser first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.37M in Q1 2026. 3,145 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • DoubleLine ETF Adviser held 6,079 shares of Amgen worth $2.2M as of Q2 2026.
  • DoubleLine ETF Adviser sold 651 Amgen shares in Q2 2026, an estimated $223K.
  • Amgen made up 0.91% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #35 holding.
  • DoubleLine ETF Adviser first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • DoubleLine ETF Adviser's Amgen position peaked at $2.37M in Q1 2026.
  • 3,145 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.